NCT01621269View on ClinicalTrials.gov

ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Multiple Sclerosis
Interventions
DRUG

Fingolimod

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01621269 - ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon | Biotech Hunter | Biotech Hunter